# OnCo record lymphoma-tx-regimen-alphabet (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-tx-regimen-alphabet/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-tx-regimen-alphabet" ;
  schema:name "The lymphoma regimen alphabet: R-CHOP, pola-R-CHP, DA-EPOCH-R, ABVD, BEACOPP and the rest"@en ;
  schema:alternateName "Lymphoma chemotherapy acronyms"@en, "R-CHP"@en, "DA-EPOCH-R"@en, "R-ICE"@en, "R-DHAP"@en, "R-GemOx"@en, "CODOX-M/IVAC"@en, "MATRix"@en, "BrECADD"@en, "SMILE"@en, "CHOEP"@en, "VR-CAP"@en, "R-CVP"@en, "BR"@en ;
  schema:description "Lymphoma treatment is written in acronyms, one letter per drug. This entry spells out the ones a patient will see on a chart or a consent form, and says which disease each belongs to."@en ;
  schema:url <https://onco.cc/terms/lymphoma-tx-regimen-alphabet/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.18.01994>, <https://doi.org/10.1200/JCO.20.00303>, <https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/burkitt-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/primary-cns-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/polatuzumab-vedotin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/dacarbazine/>, <https://onco.cc/drugs/procarbazine/>, <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/thiotepa/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/bortezomib/> ;
  onco:terms <https://onco.cc/terms/r-chop/>, <https://onco.cc/terms/abvd-beacopp/>, <https://onco.cc/terms/lymphoma-tx-maintenance/> .